Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Artemisinin Stories

2009-11-19 13:04:00

WASHINGTON, Nov. 19 /PRNewswire/ -- Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). The prospect of spreading artemisinin resistance is...

2009-11-18 14:00:00

WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- While efforts to control and eliminate malaria have made great strides during the past five years, the looming specter of drug resistance heightens the importance of continued research and development for new tools to assure continued success, according to malaria scientists and public health experts appearing today on Capitol Hill. The briefing, sponsored by the American Society for Tropical Medicine and Hygiene (ASTMH), PATH, and Malaria No...

2009-11-12 12:43:58

Top scientists reveal the latest innovations in genetically modified mosquitoes, new diagnostic tests and mapping mosquito migrations In a novel approach at disseminating scientific research, the Johns Hopkins Malaria Research Institute (JHMRI) will hold a web summit to release the latest breakthroughs in malaria research, including new approaches to boosting mosquito immunity to malaria, mapping mosquito migrations, and the promise of a rapid sputum test that could revolutionize the way...

2009-11-02 07:30:00

Unprecedented data from ACTwatch unveils low accessibility of ACTs ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk. Announcing the results at the 5th Multilateral Initiative on Malaria (MIM)...

9818aa78ac77a4fac00f80c9890a24b61
2009-09-11 09:34:46

NSF-supported researchers use synthetic biology technology to engineer the next generation of biofuels Microbes such as the yeast we commonly use in baking bread and fermenting beer are now being engineered to produce the next generation of biofuels. Jay Keasling, a professor of chemical engineering at the University of California, Berkeley, is leading a team of scientists in an effort to manipulate the chemistry within bacteria so they will produce fuel from sugar. At the Joint BioEnergy...

2009-08-13 15:04:14

Doctors should ask patients if they are taking herbal supplements because of potential interaction with medications, U.S. health officials advise. The Centers for Disease Control and Prevention's Mortality and Morbidity Weekly Report say artemisinin has been available in the United States without prescription as an herbal supplement for at least 10 years. It is marketed for general health maintenance, treatment of parasitic infections and certain cancers, the report says. In 2008, the CDC...

a39c25d18869d7738a3bbed65324dbb61
2009-07-30 11:10:00

A new study suggests that scientists may finally be on the right track to developing an effective vaccine against malaria, one of mankind's top killers, The Associated Press reported. European researchers called it only a small proof-of-principle test that isn't practical on a large scale, but in a daring new experiment, the researchers actually used mosquitoes to deliver a "vaccine" of live malaria parasites to people through their bites. The results showed that everyone in the vaccine...

2009-07-30 09:16:36

Malaria parasites in western Cambodia have become resistant to artemisinin-based therapies, the first-line treatment for malaria, according to a study published in the New England Journal of Medicine today. Resistance to the drugs makes them less effective and could eventually render them obsolete, putting millions of lives at risk.Signs of artemisinin resistance have been reported in the region already, but this new research is the first detailed study of the problem. The study was funded by...

2009-07-21 13:43:00

A new subsidy designed to increase access to life-saving antiretrovirals must remain focused on quality patient care if it is to succeed, argues Tido von Schoen-Angerer and colleagues in this week's open access journal PLoS Medicine. The subsidy, called the Affordable Medicines Facility"“malaria (AMFm), will be rolled out in 2009 and is designed to address concerns of poor access to artemisinin combination therapies (ACTs) for malaria, and fears about growing resistance to the drugs....

2009-07-14 08:44:01

Eliminating polio everywhere will require global cooperation on several fronts, including lowering the cost for poor countries to vaccinate with inactivated polio vaccine (IPV), says a leading global health researcher in the July/August Health Affairs thematic issue on global health.Eradicating the wild polioviruses was supposed to have been achieved by 2000, but the effort to fight the disease is still ongoing. Polio cases reached an all-time high this century --1,997 cases -- in 2006. In...